In YAC128 mouse model of HD, QRX-704 administered ICV-activated formation of HTTΔ12 with no major change to global protein folding and biochemistry after HTT exon 12 truncation (QRX-704, 2020). The gene discussed is HTT; the disease is Huntington disease.